![Novo Nordisk A/S Website](https://finchat.io/assets/logos/323452.png)
Novo Nordisk A/S
CPSE-NOVO B
Basic
Market Cap
DKK 3,874.44B
EV
DKK 3,892.06B
Shares Out
4,434.52M
Revenue
DKK 244.24B
Employees
66,015
Margins
Gross
84.65%
EBITDA
48.25%
Operating
45.38%
Pre-Tax
45.8%
Net
36.55%
FCF
26.13%
Returns (5Yr Avg)
ROA
30.08%
ROTA
135.05%
ROE
77.41%
ROCE
78.87%
ROIC
32.73%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
DKK 964.56
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
DKK 9,303M
Net Debt
DKK 17.63B
Debt/Equity
0.27
EBIT/Interest
204.48
Growth (CAGR)
Rev 3Yr
24.4%
Rev 5Yr
16.42%
Rev 10Yr
11.27%
Dil EPS 3Yr
29.35%
Dil EPS 5Yr
20.18%
Dil EPS 10Yr
15.31%
Rev Fwd 2Yr
23.19%
EBITDA Fwd 2Yr
25.87%
EPS Fwd 2Yr
24.61%
EPS LT Growth Est
21%
Dividends
Yield
—
Payout
47.1%
DPS
DKK 9.4
DPS Growth 3Yr
27.36%
DPS Growth 5Yr
18.2%
DPS Growth 10Yr
15.37%
DPS Growth Fwd 2Yr
24.56%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)